UBS Group AG - PROTAGENIC THERAPEUTICS INC ownership

PROTAGENIC THERAPEUTICS INC's ticker is PTIX and the CUSIP is 74365N103. A total of 18 filers reported holding PROTAGENIC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROTAGENIC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,861
+71.5%
17,153
+164.8%
0.00%
Q3 2022$4,000
+300.0%
6,477
+535.0%
0.00%
Q2 2022$1,000
-50.0%
1,020
-57.4%
0.00%
Q1 2022$2,000
-75.0%
2,393
-56.7%
0.00%
Q4 2021$8,000
-20.0%
5,525
+5.5%
0.00%
Q3 2021$10,000
+11.1%
5,239
+73.9%
0.00%
Q2 2021$9,0003,0120.00%
Other shareholders
PROTAGENIC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 75,000$61,0000.06%
ORACLE INVESTMENT MANAGEMENT INC 20,000$16,0000.00%
Virtu Financial LLC 13,045$11,0000.00%
Renaissance Technologies 102,200$83,0000.00%
ROYAL BANK OF CANADA 1$00.00%
VANGUARD GROUP INC 252,825$206,0000.00%
UBS Group AG 2,393$2,0000.00%
OSAIC HOLDINGS, INC. 5,055$4,0000.00%
BANK OF AMERICA CORP /DE/ 4$00.00%
WELLS FARGO & COMPANY/MN 85$00.00%
View complete list of PROTAGENIC THERAPEUTICS INC shareholders